LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Oral ketotifen associated with famotidine for the treatment of facial melasma: a randomized, double‐blind, placebo‐controlled trial

Photo from wikipedia

Upper dermal mast cells are markers of chronic photoexposure and they are more prominent in melasma than in unaffected adjacent skin.1 As mast cells degranulate under stimulation (e.g., heat, UV… Click to show full abstract

Upper dermal mast cells are markers of chronic photoexposure and they are more prominent in melasma than in unaffected adjacent skin.1 As mast cells degranulate under stimulation (e.g., heat, UV exposure), and several treatments for melasma, such as oral tranexamic acid, topical nicotinamide, and topical corticosteroids reduce them, such cells are thought to play a key role in melasma pathogenesis.2,3 To date, there are no studies exploring the stabilization of mast cells and H2 blockade as a potential therapeutic strategy in melasma.

Keywords: oral ketotifen; famotidine treatment; ketotifen associated; mast cells; melasma; associated famotidine

Journal Title: Journal of the European Academy of Dermatology and Venereology
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.